Skip to main content

Advertisement

SpringerLink
Log in

The good, the bad and the ugly: rectal cancers in the twenty-first century

  • Controversies in Colorectal Surgery
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Frykholm GJ, Glimelius B, Påhlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564–572

    Article  CAS  PubMed  Google Scholar 

  2. Cedermark B, Johansson H, Rutqvist LE, Wilking N (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75:2269–2275

    Article  CAS  PubMed  Google Scholar 

  3. Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336:980–987

    Article  CAS  PubMed  Google Scholar 

  4. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Stockholm Colorectal Cancer Study Group (2001) The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 92:896–902

    Article  CAS  PubMed  Google Scholar 

  5. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646

    Article  CAS  PubMed  Google Scholar 

  6. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  CAS  PubMed  Google Scholar 

  7. Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926–1933

    Article  CAS  PubMed  Google Scholar 

  8. van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–582

    Article  PubMed  Google Scholar 

  9. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223

    Article  CAS  PubMed  Google Scholar 

  10. Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719

    Article  PubMed  Google Scholar 

  11. Blomqvist L, Glimelius B (2008) The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncol 47:5–8

    Article  PubMed  Google Scholar 

  12. Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820

    Article  PubMed  PubMed Central  Google Scholar 

  13. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126–6131

    Article  PubMed  Google Scholar 

  14. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B, Swedish Rectal Cancer Trial Group (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697–8705

    Article  PubMed  Google Scholar 

  15. Loos M, Quentmeier P, Schuster T et al (2013) Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 20:1816–1828

    Article  PubMed  Google Scholar 

  16. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–771 (discussion 717–718)

    PubMed  PubMed Central  Google Scholar 

  17. Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP et al (2014) Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 88:822–828

    Article  PubMed  Google Scholar 

  18. Renehan AG, Malcomson L, Emsley R et al (2016) Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 17:174–183

    Article  PubMed  Google Scholar 

  19. Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG (2017) Outcome and salvage surgery following “Watch and Wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 60:335–345

    PubMed  Google Scholar 

  20. Appelt AL, Ploen J, Harling H et al (2015) High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 16:919–927

    Article  PubMed  Google Scholar 

  21. Martens MH, Maas M, Heijnen LA et al (2016) Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst 108(12):djw171. doi:10.1093/jnci/djw171

    Article  PubMed  Google Scholar 

  22. Perez RO, Habr-Gama A, Sao Juliao GP et al (2014) Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Tech Coloproctol 18:699–708

    Article  CAS  PubMed  Google Scholar 

  23. Garcia-Aguilar J, Renfro LA, Chow OS et al (2015) Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol 16:1537–1546

    Article  PubMed  PubMed Central  Google Scholar 

  24. Habr-Gama A, Sao Juliao GP, Gama-Rodrigues J, Vailati BB, Ortega C, Fernandez LM et al (2017) Baseline T classification predicts early tumor regrowth after nonoperative management in distal rectal cancer after extended neoadjuvant chemoradiation and initial complete clinical response. Dis Colon Rectum 60:586–594

    Article  PubMed  Google Scholar 

  25. Habr-Gama A, Gama-Rodrigues J, Perez RO (2013) Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation? Dis Colon Rectum 56:264–266

    Article  PubMed  Google Scholar 

  26. Habr-Gama A, Sabbaga J, Gama-Rodrigues J et al (2013) Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 56:1109–1117

    Article  PubMed  Google Scholar 

  27. Garcia-Aguilar J, Chow OS, Smith DD et al (2015) Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16:957–966

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Habr-Gama A, Perez RO, Sao Juliao GP et al (2016) Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiat Oncol 11:24

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Angelita & Joaquim Gama Institute, São Paulo, SP, Brazil

    G. P. São Julião, A. Habr-Gama, B. B. Vailati & R. O. Perez

  2. Colorectal Surgery Division, University of São Paulo School of Medicine, São Paulo, SP, Brazil

    R. O. Perez

  3. Ludwig Institute for Cancer Research, São Paulo Branch, São Paulo, SP, Brazil

    R. O. Perez

Authors
  1. G. P. São Julião
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Habr-Gama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. B. Vailati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. O. Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. O. Perez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by the authors.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

São Julião, G.P., Habr-Gama, A., Vailati, B.B. et al. The good, the bad and the ugly: rectal cancers in the twenty-first century. Tech Coloproctol 21, 573–575 (2017). https://doi.org/10.1007/s10151-017-1651-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-017-1651-7

Keywords

Search

Navigation